Cargando…
Estimation of the stage-wise costs of breast cancer in Germany using a modeling approach
Breast cancer (BC) is a heterogeneous disease representing a substantial economic burden. In order to develop policies that successfully decrease this burden, the factors affecting costs need to be fully understood. Evidence suggests that early-stage BC has a lower cost than a late stage BC. We aim...
Autores principales: | Khan, Shah Alam, Hernandez-Villafuerte, Karla, Hernandez, Diego, Schlander, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853539/ https://www.ncbi.nlm.nih.gov/pubmed/36684975 http://dx.doi.org/10.3389/fpubh.2022.946544 |
Ejemplares similares
-
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany
por: HERNANDEZ, DIEGO, et al.
Publicado: (2023) -
Economic Burden of Pancreatic Cancer in Europe: a Literature Review
por: Hernandez, Diego, et al.
Publicado: (2022) -
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment
por: Schlander, Michael, et al.
Publicado: (2021) -
Cancer cost profiles: The Epicost estimation approach
por: Francisci, Silvia, et al.
Publicado: (2022) -
The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden
por: Eckford, Rachel D., et al.
Publicado: (2022)